Thrombosis in anti-cancer therapy by bortezomib for multiple myeloma

Thrombosis in anti-cancer therapy by bortezomib for multiple myeloma - Bortezomib and thrombosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009903

Enrollment

Registered

2013-01-30

Start date

2013-01-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

Bortemizob

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: multiple myeloma

Exclusion criteria

Exclusion criteria: pregnancy and allergy

Design outcomes

Primary

Measure	Time frame
measurement of thrombosis-related markers	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026